TGOLN2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.6251444634463E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.37440075881545E-11 |
Normal-vs-Stage2 |
1.57460000005383E-06 |
Normal-vs-Stage3 |
1.62725388719309E-12 |
Normal-vs-Stage4 |
1.62525548574877E-12 |
Stage1-vs-Stage2 |
3.770800E-01 |
Stage1-vs-Stage3 |
2.340100E-03 |
Stage1-vs-Stage4 |
1.402360E-04 |
Stage2-vs-Stage3 |
2.957200E-01 |
Stage2-vs-Stage4 |
8.182000E-02 |
Stage3-vs-Stage4 |
3.221600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62592161956354E-12 |
Normal-vs-AfricanAmerican |
1.10260023333808E-10 |
Normal-vs-Asian |
2.304400E-02 |
Caucasian-vs-AfricanAmerican |
4.191400E-01 |
Caucasian-vs-Asian |
4.970400E-01 |
AfricanAmerican-vs-Asian |
3.047800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
3.08160053030804E-10 |
Male-vs-Female |
1.283910E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.59111999999961E-05 |
Normal-vs-Age(41-60Yrs) |
1.5709655798446E-13 |
Normal-vs-Age(61-80Yrs) |
1.0325074129014E-14 |
Normal-vs-Age(81-100Yrs) |
2.751800E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.637830E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.825000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.476000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.369000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.967800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.716200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.264030E-01 |
Normal-vs-Grade 2 |
9.01699825917035E-11 |
Normal-vs-Grade 3 |
1.62525548574877E-12 |
Normal-vs-Grade 4 |
1.62458935193399E-12 |
Grade 1-vs-Grade 2 |
1.361600E-01 |
Grade 1-vs-Grade 3 |
2.055900E-02 |
Grade 1-vs-Grade 4 |
6.578300E-04 |
Grade 2-vs-Grade 3 |
1.076200E-02 |
Grade 2-vs-Grade 4 |
4.1354000000049E-05 |
Grade 3-vs-Grade 4 |
3.171900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.56270000051251E-07 |
Normal-vs-ccB subtype |
2.44249065417534E-15 |
ccA subtype-vs-ccB subtype |
1.180160E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.8419710201556E-12 |
Normal-vs-N1 |
2.342100E-02 |
N0-vs-N1 |
9.323200E-01 |
|
|